AAAAAA

   
Results: 1-11 |
Results: 11
Long-acting beta(2)-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma - A randomized controlled trial
Authors: Lazarus, SC Boushey, HA Fahy, JV Chinchilli, VM Lemanske, RF Sorkness, CA Kraft, M Fish, JE Peters, SP Craig, T Drazen, JM Ford, JG Israel, E Martin, RJ Mauger, EA Nachman, SA Spahn, JD Szefler, SJ
Citation: Sc. Lazarus et al., Long-acting beta(2)-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma - A randomized controlled trial, J AM MED A, 285(20), 2001, pp. 2583-2593
Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol - A randomized controlled trial
Authors: Lemanske, RF Sorkness, CA Mauger, EA Lazarus, SC Boushey, HA Fahy, JV Drazen, JM Chinchilli, VM Craig, T Fish, JE Ford, JG Israel, E Kraft, M Martin, RJ Nachman, SA Peters, SP Spahn, JD Szefler, SJ
Citation: Rf. Lemanske et al., Inhaled corticosteroid reduction and elimination in patients with persistent asthma receiving salmeterol - A randomized controlled trial, J AM MED A, 285(20), 2001, pp. 2594-2603
Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma
Authors: Cover, RA Leung, DYM McCormick, D Steelman, J Zeitler, P Spahn, JD
Citation: Ra. Cover et al., Risk factors associated with glucocorticoid-induced adverse effects in children with severe asthma, J ALLERG CL, 106(4), 2000, pp. 651-659
Glucocorticoid therapy in asthma
Authors: Spahn, JD Szefler, SJ
Citation: Jd. Spahn et Sj. Szefler, Glucocorticoid therapy in asthma, CUR CL PRAC, 2000, pp. 385-404
Inhaled glucocorticoids
Authors: Spahn, JD Szefler, SJ
Citation: Jd. Spahn et Sj. Szefler, Inhaled glucocorticoids, LUNG BIOL H, 145, 2000, pp. 1-52
Inhaled glucocorticoids, established and new
Authors: Spahn, JD Szefler, SJ
Citation: Jd. Spahn et Sj. Szefler, Inhaled glucocorticoids, established and new, LUNG BIOL H, 139, 2000, pp. 155-181
Immunologic basis and management of steroid-resistant asthma
Authors: Leung, DYM Spahn, JD Szefler, SJ
Citation: Dym. Leung et al., Immunologic basis and management of steroid-resistant asthma, ALL ASTH P, 20(1), 1999, pp. 9-14
Clinical outcomes of steroid-insensitive asthma
Authors: Wamboldt, FS Spahn, JD Klinnert, MD Wamboldt, MZ Gavin, LA Szefler, SJ Leung, DYM
Citation: Fs. Wamboldt et al., Clinical outcomes of steroid-insensitive asthma, ANN ALLER A, 83(1), 1999, pp. 55-60
Glucocorticoid pharmacokinetics
Authors: Spahn, JD
Citation: Jd. Spahn, Glucocorticoid pharmacokinetics, IMMUNOL ALL, 19(4), 1999, pp. 709
Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy
Authors: Fost, DA Leung, DYM Martin, RJ Brown, EE Szefler, SJ Spahn, JD
Citation: Da. Fost et al., Inhibition of methylprednisolone elimination in the presence of clarithromycin therapy, J ALLERG CL, 103(6), 1999, pp. 1031-1035
Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin
Authors: Spahn, JD Leung, DYM Chan, MTS Szefler, SJ Gelfand, EW
Citation: Jd. Spahn et al., Mechanisms of glucocorticoid reduction in asthmatic subjects treated with intravenous immunoglobulin, J ALLERG CL, 103(3), 1999, pp. 421-426
Risultati: 1-11 |